Thanks girls for the heads up on VIT, looks very interesting. As for CLV I read a free report from Microequities Asset Management, about 2 years ago (which I don't have now) on my old computer that died, they stated that if phase 3 clinical trials were a success, this could be a company maker, But still considered CLV to be speculative! I suppose they will maintain this rating until the results are released & will upgrade or down grade their rating accordingly. interesting times ahead!
Colonnade
CLV Price at posting:
29.5¢ Sentiment: None Disclosure: Held